AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2021
Feb 9, 2021
284_dirs_2021-02-09_84a1ecce-0240-4e2f-8b60-e8304ebcc7b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-12-31
Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-25 | Common Stock | G | 12500 | — | Disposed | 411546.063 | Direct |
| 2020-09-17 | Common Stock | G | 15500 | — | Disposed | 411546.063 | Direct |
| 2020-10-30 | Common Stock | G | 64073 | — | Disposed | 411546.063 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock - 401(k) Plan | 4208.2792 | Indirect |
Footnotes
F1: Amount reported reflects the number of shares beneficially owned at the end of fiscal year 2020, taking into account all transactions reported here and the sale transactions reported on Form 4 filed on November 12, 2020.
F2: Includes shares acquired and dividends earned through October 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8